LATEST
Claim:
In degenerative cervical myelopathy (DCM), smartphone-assessed motor performance correlates with standard clinical grading and with postoperative improvement.
HARDLY BS
Claim:
Degenerative cervical myelopathy (DCM) severity can fluctuate over time and may not be fully captured during episodic clinic visits.
NOT BS
Claim:
Chemotherapy-induced peripheral neuropathy (CIPN) can cause persistent dysfunction of the hands and feet that interferes with daily activities and reduces quality of life.
NOT BS
Claim:
The leadership of Synanon used guilt, shame, and humiliation as psychological tactics to break down members and increase their compliance.
NOT BS
Claim:
All humans have an eight-pack (eight distinct abdominal muscle segments).
TOTAL BS
Claim:
Startups that sell claim verification via an API generally do not offer a full audit trail or grounded follow-up questioning to interrogate the verdict.
SOME BS
Claim:
Startups that sell claim verification via an API generally do not offer multi-model adversarial adjudication.
HARDLY BS
Claim:
Startups that sell claim verification via an API generally use a single-pass, single-model pipeline.
TOTAL BS
Claim:
During the lifetime of Muhammad, Islam spread among multiple tribes across the Arabian Peninsula.
NOT BS
Claim:
Russia won a legal case in The Hague concerning Crimea and the Sea of Azov.
SOME BS
Claim:
TurboTax handles about 60% of all United States tax preparation.
TOTAL BS
Claim:
Intuit Inc. is the largest consumer financial technology company in the United States.
TOTAL BS
Claim:
The United States military intentionally conducted a missile strike on a school in Iran.
TOTAL BS
Claim:
More than 35% of people in Bulgaria smoke tobacco.
HARDLY BS
Claim:
The European Union is planning to require AI-based scanning of all users' messages on private messaging apps such as WhatsApp.
MOSTLY BS
Claim:
The use of generative AI tools and trust in them has had a negative impact on non-fiction book sales.
SOME BS
Claim:
Adopting generative AI tools increases employee productivity in companies by at least 10%.
MOSTLY BS
Claim:
Genetic variants in the CYP2C19 gene that reduce CYP2C19 enzyme activity can contribute to relatively treatment-resistant depression by reducing the metabolism of some antidepressant medications.
MOSTLY BS
Claim:
Scientific studies report an association between CYP2C19 genetic variants and major depressive disorder, longer depressive episodes, and greater depressive symptom severity.
NOT BS
Claim:
The human enzyme CYP2C19 metabolizes about 10% of commonly prescribed medications, including some antidepressants, proton pump inhibitors, clopidogrel, and voriconazole.
NOT BS